HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott M Lippman Selected Research

Drug Therapy (Chemotherapy)

1/2021Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
9/2014Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy.
3/2014Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment.
7/2011Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.
5/2011Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
5/2010Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.
5/2009Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
11/2008Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
4/2008Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
10/2004The convergence of cancer prevention and therapy in early-phase clinical drug development.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott M Lippman Research Topics

Disease

162Neoplasms (Cancer)
04/2024 - 05/2002
52Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2003
29Carcinogenesis
01/2018 - 01/2002
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 08/2008
23Squamous Cell Carcinoma of Head and Neck
11/2023 - 07/2002
21Lung Neoplasms (Lung Cancer)
10/2020 - 05/2005
14Breast Neoplasms (Breast Cancer)
01/2020 - 06/2002
14Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 02/2002
11Mouth Neoplasms (Oral Cancer)
11/2021 - 12/2003
10Inflammation (Inflammations)
01/2022 - 12/2005
10Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 04/2006
10Carcinoma (Carcinomatosis)
01/2019 - 09/2003
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 01/2002
6Esophageal Neoplasms (Esophageal Cancer)
07/2006 - 01/2002
5Oral Leukoplakia
11/2023 - 03/2004
5Noninfiltrating Intraductal Carcinoma (DCIS)
01/2016 - 06/2002
5Skin Neoplasms (Skin Cancer)
01/2007 - 01/2002
4Leukoplakia
11/2023 - 03/2004
4Melanoma (Melanoma, Malignant)
10/2018 - 07/2002
4Colonic Neoplasms (Colon Cancer)
06/2008 - 08/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 08/2010
3COVID-19
01/2023 - 11/2020
3Adenocarcinoma
12/2018 - 05/2014
3Cataract (Cataracts)
01/2015 - 06/2006
3Hypoxia (Hypoxemia)
12/2013 - 06/2010
3Adenocarcinoma of Lung
01/2013 - 07/2010
3Prostatic Intraepithelial Neoplasia
11/2011 - 08/2006
3Acne Vulgaris
06/2010 - 04/2006
3Disease Progression
05/2010 - 04/2008
3Adenoma (Adenomas)
03/2009 - 10/2003

Drug/Important Bio-Agent (IBA)

31Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2002
27Finasteride (Propecia)FDA LinkGeneric
01/2018 - 07/2003
24Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2002
20SeleniumIBA
10/2017 - 01/2003
15Vitamin EFDA LinkGeneric
10/2017 - 01/2003
12RetinoidsIBA
01/2022 - 07/2003
11Prostate-Specific Antigen (Semenogelase)IBA
05/2014 - 07/2003
10DNA (Deoxyribonucleic Acid)IBA
03/2024 - 03/2004
10Messenger RNA (mRNA)IBA
06/2015 - 01/2002
9LigandsIBA
11/2023 - 11/2004
8Circulating Tumor DNAIBA
01/2023 - 01/2017
7RNA (Ribonucleic Acid)IBA
01/2024 - 03/2007
7ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2005
7TamoxifenFDA LinkGeneric
01/2016 - 09/2002
6MicroRNAs (MicroRNA)IBA
01/2016 - 02/2010
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2010 - 01/2002
6Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2009 - 01/2002
6FenretinideIBA
01/2009 - 09/2002
6PPAR gammaIBA
07/2005 - 11/2004
5Estrogens (Estrogen)FDA Link
01/2020 - 08/2011
5Hormones (Hormone)IBA
01/2020 - 10/2011
5Insulin-Like PeptidesIBA
06/2015 - 09/2009
5Isotretinoin (Accutane)FDA LinkGeneric
06/2010 - 01/2002
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2009 - 01/2003
4Vitamin A (Retinol)FDA LinkGeneric
01/2022 - 04/2006
4Cetuximab (Erbitux)FDA Link
01/2021 - 01/2010
4PlatinumIBA
01/2021 - 11/2008
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 01/2012
4AndrogensIBA
01/2020 - 07/2003
4Tyrosine Kinase InhibitorsIBA
01/2019 - 09/2009
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 06/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 06/2010
4Raloxifene Hydrochloride (Evista)FDA Link
01/2016 - 06/2006
4Phosphotransferases (Kinase)IBA
09/2012 - 12/2003
4Selenomethionine (Sethotope)FDA Link
11/2011 - 07/2005
4Paclitaxel (Taxol)FDA LinkGeneric
06/2010 - 07/2002
4VaccinesIBA
04/2010 - 12/2006
4Cyclin D1IBA
01/2009 - 09/2003
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2004 - 02/2002
3pembrolizumabIBA
03/2024 - 10/2019
3Immune Checkpoint InhibitorsIBA
09/2022 - 01/2018
3Metformin (Glucophage)FDA LinkGeneric
01/2021 - 01/2017
3Cell-Free Nucleic AcidsIBA
01/2019 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
06/2017 - 05/2016
3Interleukin-8 (Interleukin 8)IBA
06/2017 - 08/2010
3Estrogen ReceptorsIBA
01/2016 - 07/2003
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2014 - 08/2012
3Insulin-Like Growth Factor I (IGF-1)IBA
05/2014 - 09/2009
3Small Interfering RNA (siRNA)IBA
10/2013 - 03/2007
3GemcitabineFDA Link
08/2010 - 02/2009
3AcidsIBA
07/2010 - 08/2003
3Carboplatin (JM8)FDA LinkGeneric
06/2010 - 07/2002
3Docetaxel (Taxotere)FDA Link
05/2010 - 11/2008
3ProstaglandinsIBA
11/2009 - 05/2005
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2009 - 03/2004
3Interferon-alpha (Interferon Alfa)IBA
05/2007 - 01/2002
3MutagensIBA
01/2007 - 05/2002
3Arachidonic Acid (Vitamin F)IBA
12/2005 - 03/2003
37,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
12/2005 - 05/2002
3retinoic acid receptor betaIBA
04/2005 - 01/2002
2trametinibIBA
03/2024 - 03/2016
2NivolumabIBA
11/2023 - 12/2017
2Carotenoids (Carotene)IBA
01/2022 - 10/2015

Therapy/Procedure

50Therapeutics
03/2024 - 07/2002
33Chemoprevention
01/2018 - 06/2002
11Drug Therapy (Chemotherapy)
01/2021 - 04/2004
6Immunotherapy
04/2024 - 10/2019
5Precision Medicine
01/2023 - 01/2016
5Radiotherapy
10/2016 - 05/2009
5Prostatectomy (Retropubic Prostatectomy)
05/2016 - 07/2005